Skip to main content
Top

Current Treatment Options in Oncology

Issue 6/2025

Content (8 Articles)

The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy

Vibor Milunović, Dora Dragčević, Martina Bogeljić Patekar, Inga Mandac Smoljanović, Slavko Gašparov

Advances in Targeted Therapy for Metastatic Prostate Cancer

Kabir Grewal, Tanya B. Dorff, Sagar S. Mukhida, Neeraj Agarwal, Andrew W. Hahn

Immunotherapy-Boosted Stereotactic Ablative Radiotherapy in Inoperable Early-Stage Non-Small Cell Lung Cancer

Jie Lian, Li Sun, Shuling Zhang, Letian Huang, Jietao Ma, Chengbo Han

Epithelioid Hemangioendothelioma: Treatment Landscape and Innovations for an Ultra-Rare Sarcoma

Erica M. Pimenta, Anirudh Goyal, Orly N. Farber, Elizabeth Lilley, Paul B. Shyn, Jiping Wang, Michael J. Wagner

ASCO 2025 Annual Meeting

Keep up to date with the latest in oncology research with our ASCO 2025 hub page, featuring official videos, breaking news, and more.

Read more

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more